Form 13-F position report

APOLLO MEDICAL HLDGS INC

Reported by NorthCrest Asset Manangement LLC

AMEH CUSIP 03763A207 Manager CIK 0001893159

Reported 203,583 shares, up 3,678 (1.8%) from the prior quarter.

Reported value 26.4%; share count 1.8% vs. the prior quarter.

Added
% of reported 13F value 0.29% This manager · Q4 2023
Shares 203,583 Quarter-end amount reported
Reported value $7,797,229 Fair value at quarter end
Consecutive quarters held 4 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-03-31 7291484
2023-06-30 6317820
2023-09-30 6167069
2023-12-31 7797229
2024-03-31 8547610
2024-06-30 8053715
2024-09-30 26704256
2024-12-31 14153881
2025-03-31 13920761
2025-06-30 11348243
2025-09-30 13599396
2025-12-31 12342741
2026-03-31 0
2026-06-30 1024999
2026-09-30 5721086

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for APOLLO MEDICAL HLDGS INC held by NorthCrest Asset Manangement LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 159,495 +137,598 (628.4%) 0.13% $5,721,086 2026-10-09
Q2 2026 New 21,897 +21,897 (0.0%) 0.03% $1,024,999 2026-07-15
Q1 2026 Reduced 0 -450,465 (-100.0%) 0 $0 2026-04-08
Q4 2025 Added 450,465 +2,084 (0.5%) 0.28% $12,342,741 2026-01-08
Q3 2025 Reduced 448,381 -521 (-0.1%) 0.32% $13,599,396 2025-10-29
Q2 2025 Reduced 448,902 -10 (0.0%) 0.3% $11,348,243 2025-07-10
Q1 2025 Added 448,912 +10 (0.0%) 0.42% $13,920,761 2025-04-16
Q4 2024 Reduced 448,902 -11,993 (-2.6%) 0.42% $14,153,881 2025-01-10
Q3 2024 Added 460,895 +262,332 (132.1%) 0.81% $26,704,256 2024-10-24
Q2 2024 Reduced 198,563 -5,000 (-2.5%) 0.27% $8,053,715 2024-07-16
Q1 2024 Reduced 203,563 -20 (0.0%) 0.29% $8,547,610 2024-04-15
Q4 2023 Added 203,583 +3,678 (1.8%) 0.29% $7,797,229 2024-01-30
Q3 2023 Reduced 199,905 -26 (0.0%) 0.25% $6,167,069 2023-11-13
Q2 2023 Unchanged 199,931 0 (0.0%) 0.25% $6,317,820 2023-07-21
Q1 2023 New 199,931 +199,931 (0.0%) 0.3% $7,291,484 2023-04-25

Who else reported the position

156 managers reported APOLLO MEDICAL HLDGS INC for Q4 2023.

Managers reporting APOLLO MEDICAL HLDGS INC in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 6,498,075 -30,420 < 0.01% $248,876,273 23 qtrs
VANGUARD GROUP INC Added 5,049,928 +260,687 < 0.01% $193,412,242 23 qtrs
STATE STREET CORPORATION Reduced 1,546,620 -50,407 < 0.01% $59,235,546 23 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 944,449 +42,278 < 0.01% $36,176,355 23 qtrs
DIMENSIONAL FUND ADVISORS LP Added 768,520 +59,895 < 0.01% $29,437,651 22 qtrs
Steel Peak Wealth Management LLC Added 677,176 +65,000 1.5% $25,935,841 9 qtrs
325 CAPITAL LLC Unchanged 592,810 0 11.25% $22,704,623 6 qtrs
NORTHERN TRUST CORPORATION Reduced 452,732 -14,774 < 0.01% $17,339,635 23 qtrs
MORGAN STANLEY Added 391,199 +111,202 < 0.01% $14,982,922 25 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 344,029 +13,526 < 0.01% $13,176,311 23 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
January 30, 2024
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
203,583

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.